Stay updated on CAR-T for CD33+ AML Clinical Trial
Sign up to get notified when there's something new on the CAR-T for CD33+ AML Clinical Trial page.

Latest updates to the CAR-T for CD33+ AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange Detected- Added a prominent notice about government funding lapse and current operating status, plus a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed reference to v3.1.0.SummaryDifference3%

- Check25 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.1%

- Check39 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.2%

- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check54 days agoChange DetectedThe web page has been updated to include new drug information and resources related to hematologic neoplasms, while several previous entries regarding specific drugs and genetic resources have been removed.SummaryDifference5%

- Check61 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.7%

Stay in the know with updates to CAR-T for CD33+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR-T for CD33+ AML Clinical Trial page.